Voluntary Medical Male CircumcisionVMMC NEXUSNCT06364891
Assessing the Impact of a Digital VMMC Platform
A study testing VMMC NEXUS Digital application in people with Voluntary Medical Male Circumcision, run by University of Alabama at Birmingham at 1 site in Zambia.
Trial summary
VMMC has been identified as a crucial intervention by UNAIDS to achieve the 2030 global target of a 90% reduction in new HIV infections compared with 2010 levels. CIDRZ, a key partner to the Ministry of Health, has worked with DesireLine to develop a mobile application that supports mobilisers to segment potential… Read more about this study
- Who is it for?
- Ages 18 years and older, men onlyHealthy volunteers can take part
- Conditions the study is for
- Voluntary Medical Male Circumcision
- What is being tested?
- VMMC NEXUS Digital application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150,383 participants
- Where
- 1 siteZambia
- Study dates
- 1 Oct 2023to 30 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- living in the catchment area 18 or older
Who cannot join
- nil
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessing the Impact of a Segment-targeted Mobilization Model Supported by a Digital VMMC Platform on Uptake of VMMC Services in Zambia
VMMC has been identified as a crucial intervention by UNAIDS to achieve the 2030 global target of a 90% reduction in new HIV infections compared with 2010 levels. CIDRZ, a key partner to the Ministry of Health, has worked with DesireLine to develop a mobile application that supports mobilisers to segment potential clients and provide them with targeted messaging based on their segmentation type. The hypothesis of our proposed study is that targeted interventions addressing the barriers for each of the seven segments, assisted by the Digital Mobilization Tool, will better meet the needs of potential clients and therefore improve uptake of VMMC services, specifically among the three most-resistant segments.
The objective of this study is to evaluate the effect of a segment-targeted mobilization intervention supported by the VMMC NEXUS Digital Mobilization Tool on the uptake of VMMC services at 30 intervention sites, compared with 30 control sites.
Read more
The research questions are:
- What is the effect of segment-targeted mobilization interventions designed to address the specific psycho-behavioral barriers each of the seven segments face, supported by the VMMC NEXUS Digital Mobilization Tool, on the overall numbers of men receiving VMMC in each site?
- What is the effect of the same on the numbers of men by segment receiving VMMC in each site?
- What is the effect of the same on the numbers of men by age receiving VMMC in each site?
Secondary goals will be the following, to the extent possible:
- Assess the incremental cost of the intervention, including by MC
- Assess and document process learnings from the intervention
- Develop a workplan to enable national and regional scale-up of the mobilization model and NEXUS Digital Mobilization Tool if demonstrated as effective
Read the detailed description
Study design
The study is a cluster randomised study. Programmatic data will be collected at 60 health-facility sites offering VMMC:
- 30 sites randomly selected as intervention sites
- 30 sites randomly selected as control sites Mobilizers associated with the intervention sites will mobilize men for VMMC using the segment targeted interventions for all seven segments, supported by the VMMC NEXUS Digital Mobilization Tool. At the control sites, mobilizers will use the current standard of care tools to engage men for VMMC; these tools are not digital and do not contain the targeted messaging for the three most-resistant segments. One study-supported mobilizer will be placed in each of the 60 sites to support mobilization of men for VMMC in the intervention and control sites as described above.
Mobilizer Training and Specialization The 60 mobilizers (one for each site, control or intervention) will be compensated with a monthly stipend and all will be trained on the basics of VMMC as an HIV prevention method and active listening approaches to educating clients about VMMC.
Mobilizers at the 30 intervention sites additionally will be trained on the VMMC segmentation and barriers men face to getting VMMC. Also they will be trained on use of the VMMC NEXUS Digital Mobilization Tool and on outreach approaches to the three most-resistant segments of men. Data entered by the mobilizers supporting the intervention sites as a part of their routine use of the VMMC NEXUS Digital Mobilization Tool to support their mobilization efforts will be monitored by the CIDRZ program team. Ongoing oversight and support will be provided to all mobilizers as part of routine management for both control and intervention sites.
Site Selection In order to control for potential differences between implementing partners, the study will use only those sites currently receiving technical assistance from CIDRZ. To select sites, the investigators reviewed data on the aggregate monthly number of MCs performed over a 24-month period (October 2020 - September 2022) at 893 health facilities that receive technical support from CIDRZ, in four provinces. Selection focused on the most active facilities by first selecting the sites that had performed at least 10 MCs in at least 1 month within the 24-month period. This yielded 777 sites. Next, those sites that had performed at least 10 MCs monthly in at least 18 months of the 24-month period were selected. There were 131 of these sites. To further refine the eligibility criteria, within each province sites were divided into rural and urban settings. Within each of these 8 categories (4 provinces X 2 types of setting) sites that reached at least the 25th percentile of average monthly volume of MCs were selected. This ensured a representative sample of active rural and active urban sites within each province, accounting for the fact that the average MC volume varies by province and setting. These sites were then randomly assigned to the intervention group or the control group to be balanced between groups controlling for the following: volume of Shang Ring procedures, volume of surgical procedures, volume of each of the 7 segments, province proportions and urban-rural proportions.
Methodology The study will record the number of men being engaged by the intervention mobilization efforts vs. the number receiving VMMC will be used to evaluate "conversion rates," both overall and by segment. The VMMC NEXUS Digital Tablet Mobilization Tool will facilitate data collection and tracking for this metric.
For men coming into facilities for VMMC, a standardised intake form, which includes a segmenting tool, will be used to record which segment a man belongs to and other demographic data, including age. The intake form will also collect information on which interventions men were exposed to before coming to the facility for VMMC. These data will be aggregated across facilities in localities where study mobilizers are using the Digital Mobilization Tool (intervention sites), and facilities where mobilisers are using the current standard of care tools (control sites).
The study team will extract aggregated weekly data, including VMMC volume data by segment and age. These data will be tracked for up to 6 months before the intervention is launched, and then for a period of 9-12 months after, to determine whether the intervention sites produce a higher volume of MCs than the control sites, and whether MC volumes among the three more-resistant segments are higher at the intervention sites than at the control sites.
Process Evaluation To assess the fidelity of the implementation of the interventions a process evaluation will be completed, including qualitative one-on-one interviews of key stakeholders in the pilot implementation including a selection of individuals from the following stakeholder groups: CIDRZ Mobilizers - control \& intervention sites, Other catchment area mobilizers - control \& intervention sites, Clients - control and intervention sites, Data officers, CIDRZ implementation team, CIDRZ NEXUS platform team, Providers, Intake counselors, Site In-charges, MoH District \& Province leaders, Sub-district coordinators, MoH national VMMC program leadership, Zambia VMMC TWG members.
The following areas of the implementation process will be covered in the interviews as appropriate for each stakeholder group: Mobilization tools, Mobilizer training and learning, Mobilization tool content and continuous improvement of content, Data collection, local area coordination and national coordination.
Costing Cost data for social marketing and demand mobilization interventions will be shared by the study team and compared to the same for control sites. Example fixed and variable costs for service delivery, e.g., provider salaries, will be used to estimate the effects of increased volumes on per overall per MC costs based on the interventions implemented.
Because there may be a difference in the number of interactions required between a mobilizer and a client prior to the client agreeing to proceed with MC, or the time required (number of minutes) per interaction, we will also utilize the following additional methods:
- Mobilizer time tracking logbooks: all mobilizers will be asked to keep a logbook of their time for a four-week period. This is to be filled out each day and includes information about the clients mobilized, their segmentation and the time spent per client.
- Mobilizer observations and interviews: researchers will observe a sample of mobilizers to better understand how they spend their time. We propose a sample of 3-4 mobilizers (sites) per province across all four study provinces, for a total number of 12-16 mobilizers (sites). Researchers will silently observe the mobilizers while they interact with clients for one day (from 8:00am-12:30pm) per site. While observing, researchers will complete a duplicate mobilizer logbook (see #1 above) for comparison, adding any relevant notes. The aim of the observation is to better understand how mobilizers interact with clients and to verify correct completion of the logbooks.
We will use the time tracking data combined with other study data to estimate the average number of interactions per client at intervention and control sites and the time per interaction. We will also compare this data with the number of clients who choose to proceed with MC.
Relevant information on site-by-site VMMC service delivery capacities and campaign activities will be collected on a weekly basis to control for these variables in subsequent analyses. The following information will be collected by site: # of Dorsal Slit Surgery provider-days in the 7-day week, # of Shang Ringy provider-days in the 7-day week, # of active CIDRZ mobilizer-days, # of active Non-CIDRZ mobilizer-days, # of MC incentives paid to non-CIDRZ mobilizers, # prisoner MCs, Stock out Shang Ring commodities, Shang Ring-related stockout details, Stock outs of other MC commodities, Dorsal Slit MC-related stockout details, Campaign week, Campaign activities, IEC materials posted or distributed in the catchment area, Notes and other comments.
- Conditions
- Voluntary Medical Male Circumcision
- Being tested
- VMMC NEXUS Digital application
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VMMC NEXUS Digital applicationOther
A handheld digital application which supports segmentation of potential VMMC Clients
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Other | Mobilisers in the intervention sites will be trained to use a digital mobile application to assist with segmenting clients and providing them with targeted messaging. Receives: Other: VMMC NEXUS Digital application |
| Control | Other | Mobilisers in the control arm have been sensitised to the segmentation process but only have access to paper based resources. Receives: Other: VMMC NEXUS Digital application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total number of VMMC's conducted in intervention vs control
The study will compare the difference in total number of VMMC's conducted in the intervention versus the control arm
Measured: at 12 months
Total number of VMMC's by segment
The total number of VMMC's conducted in both the intervention and control arm will be compared by segment (ie the specific group type the men have been assigned to).
Measured: at 12 months
Total number of VMMC's by age
The total number of VMMC's conducted in both the intervention and control arm will be compared and stratified by age group.
Measured: at 12 months
Secondary outcomes (3)
Costing
The study will assess the incremental cost of the intervention, including by MC
Measured: 12 months
Process evaluation
The study will assess the fidelity of the intervention (ie how well the inertvention was implemented) and document all process learnings (ie opportunities and obstacles, changes that were required, unanticipated challenges etc) from the intervention
Measured: 12 months
Develop a workplan and handbook to allow for the intervention to be scaled up elsewhere.
The study team will develop a template workplan and comprehensive scale up document to enable national and regional scale-up of the mobilization model and NEXUS Digital Mobilization Tool if demonstrated as effective
Measured: 3 months post study completion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2024
- Study start1 Oct 2023
- Primary completion30 Apr 2025
- Study completion30 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Voluntary Medical Male CircumcisionStudies of the same condition, open and under way.
- More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Cluster randomised control study
- Masking
- None (open label)
- Enrolment
- 150,383 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Collaborators
- Centre for Infectious Disease Research in Zambia
- Responsible party
- Principal investigator, Carolyn Bolton, University of Alabama at Birmingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06364891
- Sponsor's protocol ID
- VMMC NEXUS
- Other IDs
- INV-047777
- Acronym
- VMMC NEXUS
- Status last verified
- May 2025
- First submitted
- 25 Mar 2024
- Last updated
- 13 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessing the Impact of a Segment-targeted Mobilization Model Supported by a Digital VMMC Platform on Uptake of VMMC Services in Zambia
- ClinicalTrials.gov ID
- NCT06364891
- Acronym / sponsor ID
- VMMC NEXUS / VMMC NEXUS
- Conditions
- Voluntary Medical Male Circumcision
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 150,383 participants (actual)
- Lead sponsor
- University of Alabama at BirminghamUniversity, hospital or other
- Collaborators
- Centre for Infectious Disease Research in Zambia
- Study start
- 1 Oct 2023 (actual)
- Primary completion
- 30 Apr 2025 (actual)
- Study completion
- 30 Apr 2025 (actual)
- First posted
- 15 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
VMMC has been identified as a crucial intervention by UNAIDS to achieve the 2030 global target of a 90% reduction in new HIV infections compared with 2010 levels. CIDRZ, a key partner to the Ministry of Health, has worked with DesireLine to develop a mobile application that supports mobilisers to segment potential clients and provide them with targeted messaging based on their segmentation type. The hypothesis of our proposed study is that targeted interventions addressing the barriers for each of the seven segments, assisted by the Digital Mobilization Tool, will better meet the needs of potential clients and therefore improve uptake of VMMC services, specifically among the three most-resistant segments.
The objective of this study is to evaluate the effect of a segment-targeted mobilization intervention supported by the VMMC NEXUS Digital Mobilization Tool on the uptake of VMMC services at 30 intervention sites, compared with 30 control sites.
The research questions are:
- What is the effect of segment-targeted mobilization interventions designed to address the specific psycho-behavioral barriers each of the seven segments face, supported by the VMMC NEXUS Digital Mobilization Tool, on the overall numbers of men receiving VMMC in each site?
- What is the effect of the same on the numbers of men by segment receiving VMMC in each site?
- What is the effect of the same on the numbers of men by age receiving VMMC in each site?
Secondary goals will be the following, to the extent possible:
- Assess the incremental cost of the intervention, including by MC
- Assess and document process learnings from the intervention
- Develop a workplan to enable national and regional scale-up of the mobilization model and NEXUS Digital Mobilization Tool if demonstrated as effective
Detailed description
Study design
The study is a cluster randomised study. Programmatic data will be collected at 60 health-facility sites offering VMMC:
- 30 sites randomly selected as intervention sites
- 30 sites randomly selected as control sites Mobilizers associated with the intervention sites will mobilize men for VMMC using the segment targeted interventions for all seven segments, supported by the VMMC NEXUS Digital Mobilization Tool. At the control sites, mobilizers will use the current standard of care tools to engage men for VMMC; these tools are not digital and do not contain the targeted messaging for the three most-resistant segments. One study-supported mobilizer will be placed in each of the 60 sites to support mobilization of men for VMMC in the intervention and control sites as described above.
Mobilizer Training and Specialization The 60 mobilizers (one for each site, control or intervention) will be compensated with a monthly stipend and all will be trained on the basics of VMMC as an HIV prevention method and active listening approaches to educating clients about VMMC.
Mobilizers at the 30 intervention sites additionally will be trained on the VMMC segmentation and barriers men face to getting VMMC. Also they will be trained on use of the VMMC NEXUS Digital Mobilization Tool and on outreach approaches to the three most-resistant segments of men. Data entered by the mobilizers supporting the intervention sites as a part of their routine use of the VMMC NEXUS Digital Mobilization Tool to support their mobilization efforts will be monitored by the CIDRZ program team. Ongoing oversight and support will be provided to all mobilizers as part of routine management for both control and intervention sites.
Site Selection In order to control for potential differences between implementing partners, the study will use only those sites currently receiving technical assistance from CIDRZ. To select sites, the investigators reviewed data on the aggregate monthly number of MCs performed over a 24-month period (October 2020 - September 2022) at 893 health facilities that receive technical support from CIDRZ, in four provinces. Selection focused on the most active facilities by first selecting the sites that had performed at least 10 MCs in at least 1 month within the 24-month period. This yielded 777 sites. Next, those sites that had performed at least 10 MCs monthly in at least 18 months of the 24-month period were selected. There were 131 of these sites. To further refine the eligibility criteria, within each province sites were divided into rural and urban settings. Within each of these 8 categories (4 provinces X 2 types of setting) sites that reached at least the 25th percentile of average monthly volume of MCs were selected. This ensured a representative sample of active rural and active urban sites within each province, accounting for the fact that the average MC volume varies by province and setting. These sites were then randomly assigned to the intervention group or the control group to be balanced between groups controlling for the following: volume of Shang Ring procedures, volume of surgical procedures, volume of each of the 7 segments, province proportions and urban-rural proportions.
Methodology The study will record the number of men being engaged by the intervention mobilization efforts vs. the number receiving VMMC will be used to evaluate "conversion rates," both overall and by segment. The VMMC NEXUS Digital Tablet Mobilization Tool will facilitate data collection and tracking for this metric.
For men coming into facilities for VMMC, a standardised intake form, which includes a segmenting tool, will be used to record which segment a man belongs to and other demographic data, including age. The intake form will also collect information on which interventions men were exposed to before coming to the facility for VMMC. These data will be aggregated across facilities in localities where study mobilizers are using the Digital Mobilization Tool (intervention sites), and facilities where mobilisers are using the current standard of care tools (control sites).
The study team will extract aggregated weekly data, including VMMC volume data by segment and age. These data will be tracked for up to 6 months before the intervention is launched, and then for a period of 9-12 months after, to determine whether the intervention sites produce a higher volume of MCs than the control sites, and whether MC volumes among the three more-resistant segments are higher at the intervention sites than at the control sites.
Process Evaluation To assess the fidelity of the implementation of the interventions a process evaluation will be completed, including qualitative one-on-one interviews of key stakeholders in the pilot implementation including a selection of individuals from the following stakeholder groups: CIDRZ Mobilizers - control \& intervention sites, Other catchment area mobilizers - control \& intervention sites, Clients - control and intervention sites, Data officers, CIDRZ implementation team, CIDRZ NEXUS platform team, Providers, Intake counselors, Site In-charges, MoH District \& Province leaders, Sub-district coordinators, MoH national VMMC program leadership, Zambia VMMC TWG members.
The following areas of the implementation process will be covered in the interviews as appropriate for each stakeholder group: Mobilization tools, Mobilizer training and learning, Mobilization tool content and continuous improvement of content, Data collection, local area coordination and national coordination.
Costing Cost data for social marketing and demand mobilization interventions will be shared by the study team and compared to the same for control sites. Example fixed and variable costs for service delivery, e.g., provider salaries, will be used to estimate the effects of increased volumes on per overall per MC costs based on the interventions implemented.
Because there may be a difference in the number of interactions required between a mobilizer and a client prior to the client agreeing to proceed with MC, or the time required (number of minutes) per interaction, we will also utilize the following additional methods:
- Mobilizer time tracking logbooks: all mobilizers will be asked to keep a logbook of their time for a four-week period. This is to be filled out each day and includes information about the clients mobilized, their segmentation and the time spent per client.
- Mobilizer observations and interviews: researchers will observe a sample of mobilizers to better understand how they spend their time. We propose a sample of 3-4 mobilizers (sites) per province across all four study provinces, for a total number of 12-16 mobilizers (sites). Researchers will silently observe the mobilizers while they interact with clients for one day (from 8:00am-12:30pm) per site. While observing, researchers will complete a duplicate mobilizer logbook (see #1 above) for comparison, adding any relevant notes. The aim of the observation is to better understand how mobilizers interact with clients and to verify correct completion of the logbooks.
We will use the time tracking data combined with other study data to estimate the average number of interactions per client at intervention and control sites and the time per interaction. We will also compare this data with the number of clients who choose to proceed with MC.
Relevant information on site-by-site VMMC service delivery capacities and campaign activities will be collected on a weekly basis to control for these variables in subsequent analyses. The following information will be collected by site: # of Dorsal Slit Surgery provider-days in the 7-day week, # of Shang Ringy provider-days in the 7-day week, # of active CIDRZ mobilizer-days, # of active Non-CIDRZ mobilizer-days, # of MC incentives paid to non-CIDRZ mobilizers, # prisoner MCs, Stock out Shang Ring commodities, Shang Ring-related stockout details, Stock outs of other MC commodities, Dorsal Slit MC-related stockout details, Campaign week, Campaign activities, IEC materials posted or distributed in the catchment area, Notes and other comments.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Cluster randomised control study
| Arm | Type | Receives |
|---|---|---|
| Intervention | Other | Other: VMMC NEXUS Digital applicationMobilisers in the intervention sites will be trained to use a digital mobile application to assist with segmenting clients and providing them with targeted messaging. |
| Control | Other | Other: VMMC NEXUS Digital applicationMobilisers in the control arm have been sensitised to the segmentation process but only have access to paper based resources. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- living in the catchment area 18 or older
Key exclusion criteria (1 listed)
- nil
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VMMC NEXUS Digital applicationA handheld digital application which supports segmentation of potential VMMC Clients | Other | Control, Intervention |
Primary outcome
Total number of VMMC's conducted in intervention vs control
Time frame: at 12 months
The study will compare the difference in total number of VMMC's conducted in the intervention versus the control arm
Total number of VMMC's by segment
Time frame: at 12 months
The total number of VMMC's conducted in both the intervention and control arm will be compared by segment (ie the specific group type the men have been assigned to).
Total number of VMMC's by age
Time frame: at 12 months
The total number of VMMC's conducted in both the intervention and control arm will be compared and stratified by age group.
3 secondary outcomes
Costing
Time frame: 12 months
Process evaluation
Time frame: 12 months
Develop a workplan and handbook to allow for the intervention to be scaled up elsewhere.
Time frame: 3 months post study completion
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2025.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing VMMC NEXUS Digital application in people with Voluntary Medical Male Circumcision, run by University of Alabama at Birmingham at 1 site in Zambia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Zambia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total number of VMMC's conducted in intervention vs control (time frame: at 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2025.